Target intelligence / Profile preview

Secretoglobin family 2A member 1 (SCGB2A1)

Target
SCGB2A1
Molecular classification
Secretoglobin family, Small secreted protein, Other
01

Overview

Secretoglobin family 2A member 1 (SCGB2A1), commonly known as mammaglobin-B, is a small secreted protein encoded by the SCGB2A1 gene on chromosome 11. Highly expressed in specific glandular tissues such as breast, uterus, and prostate, SCGB2A1 may bind androgens and steroid hormones, suggesting a role in hormonal regulation. Its expression is upregulated in various cancers, including ovarian, endometrial, and breast tumors, making it a potential antigen for immunotherapy and a candidate biomarker for cancer prognosis and detection. While its precise biological function remains incompletely understood, evidence supports roles in steroid hormone modulation, cell proliferation, and lipid metabolism. SCGB2A1 interacts with chemotherapeutic agents like estramustine and participates in tumor immune responses via cytotoxic T lymphocyte recognition[1][2][3][4][5][6].

Other names
Mammaglobin-BLIPHCMGB2UGB3LPNCLPHCLacryglobinLipophilin-CMammaglobin-2
02

Mechanism of action

Immunotherapy target: SCGB2A1-expressing tumor cells can be lysed by cytotoxic T lymphocytes in ovarian cancer[5]; Possible modulation of steroid hormone signaling (indirectly influences androgen/estrogen pathways)[2][3]

03

Biological functions

Steroid hormone binding/regulationPotential regulation of androgen and estrogen/progesterone biosynthesisCell proliferationCell cycle regulationLipid metabolismOther (function not fully elucidated)
04

Disease associations

Cancer (notably breast, endometrial, and ovarian)Tumor antigen (immunotherapy target)Prognostic biomarker (especially in endometrial and ovarian cancer)
05

Safety considerations

None directly reported; as a tumor antigen, immunotherapeutic targeting risks should be assessed
06

Interacting drugs

Estramustine (binds SCGB2A1)
07

Biomarkers

Prognostic biomarker for endometrial cancer (low expression = poorer outcome)[3]Tumor antigen and biomarker for ovarian cancer diagnosis/prognosis[5]Marker for detecting disseminated breast cancer cells[1][6]

Beyond the preview

Go deeper on Secretoglobin family 2A member 1 (SCGB2A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Secretoglobin family 2A member 1 (SCGB2A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call